Inhibition of human cancer-cell proliferation by long double-stranded RNAs

Oligonucleotides

Volumn 19, Issue 1, 2009, Pages 31-40

  Akimov, Ivan A ^a   Kabilova, Tatyana O ^a   Vlassov, Valentin V ^a   Chernolovskaya, Elena L ^a  

^a INSTITUTE OF CHEMICAL BIOLOGY AND FUNDAMENTAL MEDICINE   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

DOUBLE STRANDED RNA; DOUBLE STRANDED RNA DSEGFP; DOUBLE STRANDED RNA DSMYC; INTERFERON INDUCING AGENT; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; GENE SILENCING; HUMAN; HUMAN CELL; ONCOGENE C MYC; PRIORITY JOURNAL;

BASE SEQUENCE; CELL LINE, TUMOR; CELL PROLIFERATION; HUMANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA;

EID: 61349122681     PISSN: 15454576     EISSN: None     Source Type: Journal    
DOI: 10.1089/oli.2008.0151     Document Type: Article

References (63)

1. ABLASHI, D., BERNEMAN, Z., WILLIAMS, M., STRAYER, D., KRAMARSKY, B., SUHADOLNIK, R., REICHENBACH, N., HILTZGES, P., and KOMAROFF, A. (1994). Ampligen inhibits human herpesvirus-6 in vitro. In Vivo 8, 587-591.
2. AKIRA, S., and TAKEDA, K. (2004). Toll-like receptor signalling. Nat. Rev. Immunol. 4, 499-511.
3. AMATRUDA, T.T., SIDELL, N., RANYARD, J., and KOEFFLER, H.P. (1985). Retinoic acid treatment of human neuroblastoma cells is associated with decreased N-myc expression. Biochem. Biophys. Res. Commun. 126, 1189-1195.
4. n polymerase and protein kinase. Nucleic Acids Res 19, 4939-4950.
5. BILLY, E., BRONDANI, V., ZHANG, H., MULLER, U., and FILIPOWICZ, W. (2001). Specific interference with gene expression induced by long, double-stranded RNA in mouse embryonal teratocarcinoma cell lines. Proc. Natl. Acad. Sci. U.S.A. 98, 14428-14433.
6. BULYCHYOV, L., PORYVAYEV, V., RYZHIKOV, A., KARPYSHEV, N., ALEXEEVA, A., GONCHAROVA, Y., and PLYASUNOV, I. (2003). An intensification of the antiviral and interferon-gene effects of ridostin (an interferon inducer) by cationic liposomes in vitro and in intranasal administration. Voprosy Virusologii 48, 45-47.
7. CARMICHAEL, J., DeGRAFF, W., GAZDAR, A., MINNA, J., and MITCHELL, J. (1987). Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res. 47, 936-942.
8. CETINKAYA, C., HULTQUIST, A., SU, Y., WU,. S., BAHRAM, F., PÅHLMAN, S., GUZHOVA, I., and LARSSON, L. (2007). Combined IFN-gamma and retinoic acid treatment targets the N-Myc/Max/Mad1 network resulting in repression of N-Myc target genes in MYCN-amplified neuroblastoma cells. Mol. Cancer Ther. 6, 2634-2641.
9. CHANG, X.M., CHANG, Y., and JIA, A.A. (2005). Effects of interferon-alpha on expression of hepatic satellite cell and transforming growth factor-beta1 and alpha-smooth muscle actin in rats with hepatic fibrosis. World J. Gastroenterol. 11, 2634-2636.
10. CHATTOPADHYAY, N., KHER, R., and GODBOLE, M. (1993). Inexpensive SDS/phenol method for RNA extraction from tissues. Biotechniques 15, 24-26.
11. DI MARTINO, D., PONZONI, M., CORNAGLIA-FERRARIS, P., and TONINI, G.P. (1990). Different regulation of mid-size neurofilament and N-myc mRNA expression during neuroblastoma cell differentiation induced by retinoic acid. Cell. Mol. Neurobiol. 10, 459-470.
12. DONG-HO, K., LONGO, M., HAN, Y., LUNDBERG, P., CANTIN, E., and ROSSI, J.J. (2004). Interferon induction by siRNAs and ssRNAs synthesized by polymerase. Nat. Biotechnol. 22, 321-325.
13. 1 arrest. Nature 313, 597-600.
14. ELBASHIR, S.M., HARBORTH, M.J., LEDECKNEL, W., and TUSCHL, T. (2001). Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411, 494-498.
15. ESSEY, R., MCDOUGALL, B., and ROBINSON, W. (2001). Mismatched double-stranded RNA (polyI-polyC(12)U) is synergistic with multiple anti-HIV drugs and is active against drug-sensitive and drug-resistant HIV-1 in vitro. Antiviral Res. 51, 189-202.
16. FIRE, A., XU, S., MONTGOMERY, M.K., KOSTAS, S.A., DRIVER, S.E., and MELLO, C.C. (1998). Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391, 806-811.
17. FUCHS, U., DAMM-WELK, C., and BORKHARDT, A. (2004). Silencing of disease-related genes by small interfering RNAs. Curr. Mol. Med. 4, 507-517.
18. GHEYSEN, G., and VANHOLME, B. (2007). RNAi from plants to nematodes. Trends Biotechnol. 25, 89-92.
19. GORDEN, K.B., GORSKI, K.S., GIBSON, S.J., KEDL, R.M., KIEPER, W.C., QIU, X., TOMAI, M.A., ALKAN, S.S., and VASILAKOS, J.P. (2005). Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8. J. Immunol. 174, 1259-1268.
20. GOSWAMI, P., ALBEE, L., SPITZ, D., and RID-NOUR, L. (1997). A polymerase chain reaction assay for simultaneous detection and quantitation of proto-oncogene and GAPD mRNA in different cell growth rates. Cell Prolif. 30, 271-282.
21. HAINES, D.S., SUHADOLNIK, R.J., HUBBELL, H.R., and GILLESPIE, D.H. (1992). Cellular enzymatic activities of a synthetic heteropolymer double-stranded RNA of defined size. J. Biol. Chem. 267, 18315-18319.
22. HEMMI, H., YAMAHA K., YOON U., and KATO M. (1995). Coexpression of the myc gene family members in human neuroblastoma cell lines. Biochem. Mol. Biol. Int. 36, 1135-1141.
23. HORNUNG, V., GUENTHNER-BILLER, M., BOURQUIN, C., ABLASSER, A., SCHLEE, M., UEMATSU, S., NORONHA, A., MANOHARAN, M., AKIRA, S., DE FOUGEROLLES, A., ENDRES, S., and HARTMANN, G. (2005). Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7. Nat. Med. 11, 263-270.
24. ICHIKAWA, T., NAKAO, K., NAKATA, K., HAMASAKI, K., TAKEDA, Y., KAJIYA, Y., HIGASHI, S., OHKUBO, K., KATO, Y., ISHII, N., and EGUCHI, K. (2001). Geranylgeranylacetone induces antiviral gene expression in human hepatoma cells. Biochem. Biophys. Res. Commun. 280, 933-939.
25. JACKSON, A., BURCHARD, J., SCHELTER, J., CHAU, N., CLEARY, M., LIM, L., and LINSLEY, P. (2006). Widespread siRNA "off-target" transcript silencing mediated by seed region sequence complementarity. RNA. 12, 1179-1187.
26. JANEWAY, C.A., and MEDZHITOV, R. (2002). Innate immune recognition. Annu. Rev. Immunol. 20, 197-216.
27. JUDGE, A., SOOD, V., SHAW, J., FANG, D., and McCLINTOCK, K. (2005). Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA. Nat. Biotechnol. 23, 457-462.
28. KABILOVA, T., CHERNOLOVSKAYA, E., VLADIMIROVA, A., and VLASSOV, V. (2004). Silencing of c-myc expression in tumor cells by siRNA. Nucleosides Nucleotides Nucleic Acids 23, 867-872.
29. KABILOVA, T., VLADIMIROVA, A., CHERNOLOVSKAYA, E., and VLASSOV, V. (2006a). Arrest of cancer cells proliferation by dsRNAs. Ann. N.Y. Acad. Sci. 1091, 425-436.
30. KABILOVA, T., CHERNOLOVSKAYA, E., VLADIMIROVA, A., and VLASSOV, V. (2006b). Inhibition of human carcinoma and neuroblastoma cell proliferation by anti-c-myc siRNA. Oligonucleotides 16, 15-25.
31. KABILOVA, T., VLADIMIROVA, A., REPKOVA, M., VEN'IAMINOVA, A., CHERNOLOVSKAYA, E., and VLASSOV, V. (2006c). Silencing of c-myc gene expression by enzymatically and chemically synthesized siRNAs. Mol. Biol. (MosK.) 40, 1037-1046.
32. KARIKO, K., BUCKSTEIN, M., NI, H., and WEISSMAN, D. (2005). Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. Immunity. 23, 165-175.
33. KIM, H., YANG, E., LEE, J., KIM, S.H., SHIN, J.S., PARK, J.Y., CHOI, S.J., KIM, S.J., and CHOI, I.H. (2008). Double-stranded RNA mediates interferon regulatory factor 3 activation and interleukin-6 production by engaging Toll-like receptor 3 in human brain astrocytes. Immunology 124, 480-488.
34. KIMCHI, A. (1992). Cytokine triggered molecular pathways that control cell cycle arrest. J. Cell. Biochem. 50, 1-9.
35. KUMAR, M.V., NAGINENI, C.N., CHIN, M.S., HOOKS, J.J., and DETRICK, B. (2004). Innate immunity in the retina: toll-like receptor (TLR) signaling in human retinal pigment epithelial cells. J. Neuroimmunol. 153, 7-15.
36. LEBRUN, S.J., SHPALL, R.L., and NAUMOVSKI, L. (1998). Interferon-induced upregulation and cytoplasmic localization of Myc-interacting protein Nmi. J. Interferon Cytokine Res. 18, 767-771.
37. LEE, N.D., CHEN, J., SHPALL, R.L., and NAUMOVSKI, L. (1999). Subcellular localization of interferon-inducible Myc/stat-interacting protein Nmi is regulated by a novel IFP 35 homologous domain. J. Interferon Cytokine Res. 19, 1245-1252.
38. MASYCHEVA, V., DANILENKO, Y., IGNATYEV, G., FADINA, V., and LEVAGINA, G. (1997). The formation of antiviral resistance during local treatment with interferon inducer Ridostin. Voprosy Virusologii 42, 126-128.
39. MATSUMOTO, M., KIKKAWA, S., KOHASE, M., MIYAKE, K., and SEYA, T. (2002). Establishment of a monoclonal antibody against human toll-like receptor 3 that blocks double-stranded RNA-mediated signaling. Biochem. Biophys. Res. Commun. 293, 1364-1369.
40. MELLO, C., and CONTE, D. Jr. (2004). Revealing the world of RNA interference. Nature 431, 338-342.
41. MEISTER, G., and TUSCHL, T. (2004). Mechanisms of gene silencing by double-stranded RNA. Nature 431, 343-349.
42. MINKS, M., WEST, D., BENVIN, S, GREENE, J., TS'O, P., and BAGLIONI, C. (1980). Activation of 2′,5′-oligo(A) polymerase and protein kinase of interferon-treated HeLa cells by 2′-O-methylated poly(inosinic acid):poly(cytidylic acid), correlations with interferon-inducing activity. J. Biol. Chem. 255, 6403-6407.
43. NESBIT, C.E., TERSAK, J.M., and PROCHOWNIK, E.V. (1999). Myc oncogenes and neoplastic disease. Oncogene 18, 3004-3016.
44. PAI, S.I., LIN, Y.Y., MACAES, B., MENESHIAN, A., HUNG, C.F., and WU, T.C. (2006). Prospects of RNA interference therapy for cancer. Gene Ther. 13, 464-477.
45. PELENGARIS, S., and KHAN, M. (2003). The C-MYC oncoprotein as a treatment target in cancer and other disorders of cell growth. Expert Opin. Ther. Targets 7, 623-642.
46. PONZIELLI, R., KATZ, S., BARSYTE-LOVEJOY, D., and PENN, L. (2005). Cancer therapeutics: targeting the dark side of Myc. Eur. J. Cancer 41, 2485-4501.
47. PUTHENVEETIL, S., LANDON, W., REN, J., KELNAR, K., KREBS, J., and Beal, P. (2006). Controlling activation of the RNA-dependent protein kinase by siRNAs using site-specific chemical modification. Nucleic Acids Res. 34, 4900-4911.
48. REYNOLDS, A., ANDERSON, E.M., VERMEULEN, A., FEDOROV, Y., ROBINSON, K., LEAKE, D., KARPILOW, J., MARSHALL, W.S., and KHVOROVA, A. (2006). Induction of the interferon response by siRNA is cell type- and duplex length-dependent. RNA 12, 988-993.
49. RUBIO, N., and TORRES, C. (1999). Interferon-gamma induces proliferation but not apoptosis in murine astrocytes through the differential expression of the myc proto-oncogene family. Brain Res. Mol. Brain Res. 71, 104-110.
50. SANGFELT, O. (2000). Mechanisms of interferon-induced cell cycle arrest. Front. Biosci. 5, 479-487.
51. SCHEGLOVITOVA, O., AMEGLIO, F., TRENTO, E., and ERSHOV, F. (1995). Ridostin inhibits HIV-1 replication in the T-lymphoblastoid cell line C8166. Possible role of altered cytokine production. Acta Virologica 39, 185-188.
52. SHARP, P.A. (2001). RNA interference. Genes Dev. 15, 485-490.
53. SLEDZ, C.A., HOLKO, M., DE VEER, M.J., SILVERMAN, R.H., and WILLIAMS, B.R. (2003). Activation of the interferon system by short-interfering RNAs. Nat. Cell. Biol. 5, 834-839.
54. SPENCER, C.A., and GROUDINE, M. (1991). Control of c-myc regulation in normal and neoplastic cells. Adv. Cancer Res. 56, 1-48.
55. STARK, G.R., KERR, I.M., WILLIAMS, B.R., SILVERMAN, R.H., and SCHREIBER, R.D. (1998). How cells respond to interferons. Annu. Rev. Biochem. 67, 227-264.
56. SVOBODA, P. Off-targeting and other non-specific effects of RNAi experiments in mammalian cells. (2007). Curr. Opin. Mol. Ther. 9, 248-257.
57. SVOBODA, P., STEIN, P., HAYASHI, H., and SCHULTZ, R.M. (2000). Selective reduction of dormant maternal mRNAs in mouse oocytes by RNA interference. Development 127, 4147-4156.
58. TUSCHL, T. RNA interference and small interfering RNAs. (2001). Chembiochem 4, 239-245.
59. WADA, R.K., PAI, D.S., HUANG, J., YAMASHIRO, J.M., and SIDELL, N. (1997). Interferon-gamma and retinoic acid down-regulate N-myc in neuroblastoma through complementary mechanisms of action. Cancer Lett. 121, 181-188.
60. WIANNY, F., and ZERNICKA-GOETZ, M. (2000). Specific interference with gene function by double-stranded RNA in early mouse development. Nat. Cell. Biol. 2, 70-75.
61. YANG, S., TUTTON, S., PIERCE, E., and YOON, K. (2001). Specific double-stranded RNA interference in undifferentiated mouse embryonic stem cells. Mol. Cell. Biol. 21, 7807-7816.
62. YARDEN A., and KIMCHI, A. (1986). Tumor necrosis factor reduces c-myc expression and cooperates with interferon-gamma in HeLa cells. Science 234, 1419-1421.
63. ZAMORE, P.D., and HALEY, B. (2005). Ribo-gnome: the big world of small RNAs. Science 309, 1519-1524.